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Background: Cetirizine (anti-allergy agent) and non-steroidal anti-inflammatory drugs (NSAIDs; anti-inflammatory agents)
are co-administered drugs. Cetirizine, a P-glycopretein substrate may be affected by the use of NSAIDs. In the present
work, quantification of cetirizine in the presence of commonly co-administered NSAIDs such as diclofenac sodium,
ibuprofen, flurbiprofen, tiaprofenac acid, meloxicam and mefenamic acid were studied using the RP-HPLC technique.
Methods: A high-throughput HPLC method for the analysis of cetirizine was developed, validated in the presence of
NSAIDs and was further used to study the interactions of cetirizine in the presence of NSAIDs at four different
pH levels. Purospher Star, C18 column (5 μm, 25 cm× 0.46 cm) with a mobile phase of methanol/water (90:10 v/v, pH
adjusted to 3.5) at a flow rate of 1.0 mL/min and a wavelength of 240 nm was used.
Results: The synthesis of cetirizine in the presence of NSAIDs was carried out, and complexes were characterized using
infrared (IR) and nuclear magnetic resonance (NMR) techniques. The method was found to be applicable in serum and
was found useful for therapeutic purposes. The differences in availabilities of cetirizine with NSAIDs at three pH levels
clearly indicated the interactions of afore mentioned drugs.
Conclusions: The findings suggested further studies on the co-administration of these two drugs simultaneously in
order to know the pharmacokinetic and pharmacodynamic profiles of the drugs. It is highly recommended to have a
suitable time lapse between the oral uses of these drugs.
Keywords: Cetirizine; Drug interaction; HPLC method; NSAIDsBackground
Second- and third-generation antihistamines are P-
glycoprotein substrates. Drugs that affect the P-glyco-
protein may lead to drug-drug interactions (Scott and
Kelly 2003; Jarkko et al. 2006; Renwick 1999). Cetirizine
being a P-glycoprotein substrate may interact with com-
monly co-administered drugs such as NSAIDs that may
affect the P-glycoprotein expression (Lee et al. 2007), as
celecoxib and diclofenac, were found to inhibit the func-
tion of P-glycoprotein (Wageh et al. 2004). It has been
established that synergistic effect was exhibited by the
combined use of cetirizine with nimesulide (Rewari and
Gupta 1999). Moreover, cetirizine was found to possess
analgesic activity in mice (Priya et al. 2013). Cetirizine
and mefenamic acid combination was also developed for* Correspondence: chemdoc9@gmail.com
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in any medium, provided the original work is pthe treatment of respiratory disorder (Philip and Philip
2010). Nimesulide and cetirizine combination was also
prepared which was found to possess anti-leukotriene,
antihistamine, anti-allergy, and anti-inflammatory actions
(Singh and Jain 2003). Drug interactions of cetirizine have
also been reported in literature (Ihsan et al. 2005; Arayne
et al. 2010a; Sultana et al. 2010).
Simultaneous HPLC method for the determination of
paracetamol, phenylpropanolamine hydrochloride, and
cetirizine was reported; however, the mobile phase con-
sisted methanol and disodium hydrogen phosphate di-
hydrate buffer which could be corrosive to the column
(Suryan et al. 2011). Another simultaneous method of
paracetamol, acetyl salicylic acid, mefenamic acid, and
cetirizine was achieved using disodium hydrogen phos-
phate buffer and acetonitrile combination which could
once again be corrosive and expensive altogether (Freddy
and Dharmendra 2010). Separation method of ibuprofen,
phenylephrine HCl, and cetirizine from soft gels wasis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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nosulphonate (Cosmes and Rodriguez 2012). Simultaneous
determination of cetirizine and aceclofenac was achieved
by using mobile phase of acetonitrile and heptane sul-
phonic acid (Padmavathi and Niranjan 2011). Nimesulide,
cetirizine, and pseudoephedrine hydrochloride separation
was done by using acetonitrile/phosphate buffer/triethyl
amine as the mobile phase (Jain et al. 2012). Our group
also reported methods of simultaneous determination of
cetirizine with anti-diabetic drug (Arayne et al. 2010b) and
with H2 receptor antagonists (Sultana et al. 2010).
It is clearly evident from the above literature that most
of the simultaneous methods used acetonitrile as solvent
which is quite expensive. In others, buffers were also
used which is column corrosive. In order to quantify the
drugs and understand the degree of interactions, a fast,
least expensive, efficient HPLC method was required,
which could be used for therapeutic purposes and could
also be employed for routine analysis work.
So, in the present work, cetirizine method was developed
and validated in the presence of NSAIDs such as diclofenac
sodium, ibuprofen, flurbiprofen, meloxicam, and mefe-
namic acid using the RP-HPLC method. The method was
further used to study the interactions of the cetirizine in
the presence of NSAIDs at three pH levels, i.e., 4, 7.4, and
9. Cetirizine complexes were also synthesized with interact-
ing drugs. The synthesized complexes were characterized
by their physical parameters as well as by the techniques of
infrared (IR) and nuclear magnetic resonance (NMR).
Methods
Materials
Raw materials used were of pharmaceutical purity and for-
mulations as cetirizine (Zyrtec), mefenamic acid (Ponstan),
diclofenac sodium (Voren), flurbiprofen (Froben), meloxi-
cam (Melfex), tiaprofenic acid (Surgam), and ibuprofen
(Brofen) were purchased from local markets. Analytical
grade reagents were used during the whole experimental
procedures. Methanol of HPLC grade (TEDIA®, USA) and
other reagents included were hydrochloric acid, sodium
hydroxide, sodium chloride, potassium dihydrogen ortho-
phosphate, disodium hydrogen orthophosphate, ammonium
chloride, 10% NH3 solution, phosphoric acid 85% (Merck,
Darmstadt, Germany) were utilized.
Equipment
Shimadzu HPLC system (Kyoto, Japan) equipped with LC-
10 AT VP pump, with a 20-μl loop, Purospher® Star, RP-18
endcapped (5 μm) column and SPD-10 A VP UV-vis de-
tector was utilized. IR studies were carried out using a Shi-
madzu Model Fourier transform infrared (FTIR) Prestige-
21 spectrophotometer. Spectral treatment was performed
using Shimadzu IR solution 1.2 software. The 1H-NMR
spectra were recorded on a Bruker AMX 500 MHzspectrometer (Madison, WI, USA) using TMS as an in-
ternal standard.
Method development
Optimized conditions for separation
The chromatographic analysis was performed at laboratory
temperature (25°C) with isocratic elution. The optimized
conditions for the separation of the eluents were achieved by
using the mobile phase of methanol/water 90:10 monitored
by UV detection 240 nm at a flow rate of 1 ml min−1 with
pH 3.5 adjusted by orthophosphoric acid. The samples from
these solutions were injected in to the system six times.
Reference standard solutions
Stock reference standard solutions of all drugs were pre-
pared by dissolving appropriate amounts of each drug in a
mobile phase to yield concentrations of 100 μg ml−1. For
calibration curve studies, serial dilutions in the concentra-
tion range of 50 to 3.12 μg ml−1 were injected in triplicate.
Pharmaceutical dosage form samples
Commercially available pharmaceutical formulations
of the respective brands were evaluated by groups of
20 tablets for each drug and dissolved in mobile phase
according to the labeled claim. The samples from this
solution were injected into the system in triplicate.
Standard drug plasma solutions
The supernatant obtained by centrifuging blood samples
was deprotonated by acetonitrile, spiked daily with wor-
king solutions, and chromatographed.
Method development protocol
Certain parameters such as mobile phase composition and
pH, flow rate, diluents of solutions, and wavelength of ana-
lytes were altered in order to achieve symmetrical and
well-resolved peaks at a reasonable retention time.
Method validation
All validation steps were carried out according to the ICH
guidelines such as system suitability, selectivity, specificity,
linearity (concentration-detector response relationship),
accuracy, precision, and sensitivity, i.e., detection and
quantification limit.
System suitability
System suitability was assessed by examining the six rep-
licates of the drugs at a specific concentration for repeat-
ability, peaks symmetry (symmetry factor), theoretical
plates, resolution, and capacity factors.
Specificity
The drugs were spiked with pharmaceutical formulations
containing different excipients.
Figure 1 Representative chromatograms of (a) cetirizine and (b) meloxicam.
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The linearity of the method was evaluated at different
concentrations. Linear correlation coefficient, intercept,
and slope values were calculated for statistical analysis.Accuracy
The accuracy of the method was established at three con-
centration levels (80%, 100%, and 120%) in triplets, and
percent recovery (%recovery) was calculated in each case.Precision
Six replicates of a concentration range were injected to
system on two different non-consecutive days and per-
cent relative standard deviation (%RSD) was calculated.Figure 2 Representative chromatograms showing peaks of (a) cetirizi
(f) mefenamic acid.Limit of detection and quantification
The LOD and LOQ of the method were calculated.
Drug-drug interaction studies
The 50-μg ml−1 solutions of all the drugs alone and those
in combination with cetirizine were made and kept on
water bath for 120 min at 37°C. Five milliliters of an aliquot
was withdrawn after every 15-min interval, after making
dilutions was filtered and injected in to the HPLC system
in triplicate. The concentration of each drug was deter-
mined and %recovery was calculated.
Synthesis of cetirizine and interacting drugs
Different complexes of cetirizine with NSAIDs (diclofenac
sodium, flurbiprofen, ibuprofen, meloxicam, mefenamic
acid, tirprofenac acid) were synthesized. Equimolar solutionne, (c) tiaprofenac acid, (d) flurbiprofen, (e) ibuprofen, and
Table 1 Regression statistics and sensitivity of the
proposed method
Drugs r2 LOQ (μg ml−1) LOD (μg ml−1)
Tiaprofenac acid 0.998 0.47 0.14
Diclofenac sodium 0.999 0.56 0.24
Flurbiprofen 0.999 0.7 0.76
Ibuprofen 0.998 1.78 0.53
Mefenamic acid 0.997 0.81 0.24
Meloxicam 0.997 0.16 0.05
Table 2 Accuracy and precision of method
Drugs Conc. (μg ml−1) %RSD %recovery
Cetirizine 80 0.02 101.72
100 0.52 100.64
120 0.87 99.62
Tiaprofenac acid 80 0.99 100.44
100 0.67 101.11
120 0.47 100.84
Diclofenac sodium 80 0.14 99.83
100 0.34 102.36
120 0.56 99.98
Flurbiprofen 80 0.6 97.42
100 0.87 96.35
120 0.45 98.11
Ibuprofen 80 0.36 103.55
100 0.74 104.87
120 0.88 104.12
Mefenamic acid 80 0.12 102.66
100 0.14 100.22
120 0.72 103.99
Meloxicam 80 0.41 100.21
100 0.21 98.77
120 0.87 98.14
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solution and were refluxed for 3 h. They were then filtered
and left for drying at room temperature. Melting point and
physical characteristics of these complexes were observed.
Spectroscopic studies of complexes
Infrared studies
Cetirizine and its complexes were characterized by FTIR spec-
trophotometry using the potassium bromide disc method in
the region of 400 to 4,000 cm−1. The infrared spectra were re-
corded as attenuated total reflection (ATR) or smart performer
accessory was used for the sample (minimum amount).
1H NMR studies
Proton NMR studies were carried out on a Bruker instru-
ment in deuterated water, methanol, and chloroform using
TMS as an internal standard.
Results and discussion
Method development and validation
User friendly method in active, pharmaceutical preparations
and in serum by UV detection (240 nm) was developed for
cetirizine and tiaprofenac acid, flurbiprofen, ibuprofen and
mefenamic acid eluting out simultaneously at 2.5, 3.8, 4.8,
5.30, and 7.1 min, respectively (Figures 1 and 2). Meloxicam
and diclofenac sodium eluting out at 4.4 and 5.30 min were
determined separately in the presence of cetirizine. The
mobile phase consisted of methanol water at a ratio of
90:10 (pH 3.5) and a flow rate of 1 ml min−1. NSAIDs andTable 3 Intermediate precision of the method
Conc. (μg ml−1) Cetirizine Tiaprofenac acid Diclofenac sodium
%RSD %RSD %RSD
Intra Inter Intra Inter Intra Inter
3.12 0.03 2.25 0.53 1.18 0.8 0.97
6.25 0.65 0.24 0.85 0.16 0.78 0.36
12.5 0.07 0.82 0.33 0.64 0.62 0.47
20 0.21 0.335 0.99 1.12 0.47 0.88
25 0.599 0.87 0.74 0.85 0.23 0.29
30 0.366 0.85 0.79 0.82 0.69 0.72cetirizine separated efficiently with well-resolved and sym-
metrical peaks of all the drugs. Linearity was demonstrated
by running pharmaceutical standards at seven concentra-
tions over the range of 50 to 3.12 μg ml−1 for two consecu-
tive days. The correlation coefficient in each case was
monitored and shown in Table 1.
The mean linear regression equations of tiaprofenac
acid, diclofenac sodium, flurbiprofen, ibuprofen, mefenamic
acid, and meloxicam were found to be y = 28,166x + 54,952,
y = 19,567x + 8,726.8, y = 12,759x + 10,846, y = 6,296.4x −
6,507.9, y = 11,989x + 59,294, and y = 19,498x − 8,130,Flurbiprofen Ibuprofen Mefenamic acid Meloxicam
%RSD %RSD %RSD %RSD
Intra Inter Intra Inter Intra Inter Intra Inter
0.73 1.72 0.16 1.1 0.45 1.12 0.68 1.1
0.8 1.55 0.31 1.6 0.87 1.2 0.99 1.12
0.71 0.34 0.56 0.49 0.12 0.99 0.47 1.14
0.38 0.66 0.93 1.87 0.06 0.87 0.64 1.21
0.36 0.22 0.12 0.55 0.77 0.64 0.74 1.34
0.031 0.85 0.4 0.87 0.87 0.97 0.54 1.65
Table 4 %recoveries of proposed method
Conc. (μg ml−1) Cetirizine Tiaprofenac acid Diclofenac sodium Flurbiprofen Ibuprofen Mefenamic acid Meloxicam
Rec Fou Rec Fou Rec Fou Rec Fou Rec Fou Rec Fou Rec Fou
3.12 102.3 3.19 100.7 3.14 99.82 3.11 101.8 3.18 105.3 3.28 102 3.19 107.9 3.37
6.25 100.6 6.28 102.3 6.4 98.22 6.14 98.25 6.14 98.32 6.15 108 6.72 102.4 6.4
12.5 100.8 12.61 103.5 12.93 99.63 12.45 96.36 12.05 96.14 12.02 105 13.15 101.5 12.68
20 99.88 19.98 101.6 20.33 102 20.4 98.48 19.7 101.4 20.27 103 20.69 100.3 20.06
25 97.54 24.39 102.7 25.67 103.8 25.95 97.57 24.39 102.7 25.67 103 25.67 99.78 24.95
30 96.21 28.86 99.55 29.87 95.66 28.7 103.7 31.1 103 30.9 101 30.37 97.65 29.3
Rec, %recovery; Fou, found (μg ml−1).
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than 3%, and sensitivity of the method was also evaluated.
Precision and repeatability of the method was determined
covering the entire linearity range on two different days as
shown in Table 2. Precision of the method was expressed
in %RSD and accuracy of the method as shown in
Table 3 was achieved at three concentration ranges.
Robustness was observed by varying the wavelength in
the range of 230 to 240 nm; peak areas and retention time
changes were also observed. Results clearly indicated that
peak areas were influenced less, up to 2% for all the drugs
assayed (Table 4). Moreover, the excellent chromatograms
with good peak symmetry, unchanged retention times of
the drugs in different pH solutions also proved the robust-
ness of the method.
To evaluate the selectivity of developed method for the
analysis of formulated products, cetirizine, tiaprofenac acid,
flurbiprofen, ibuprofen, mefenamic acid, and meloxicam
tablets were analyzed, and chromatograms were compared
with the standard solution of these drugs where no interfer-
ence of excipients was observed.
The method was found to be applicable for therapeutic
purposes as the calculated %recovery (Table 5), for all
the drugs were found to be in the range of 92.45%
to 107.45% by spiking serum samples at five different
concentrations.Table 5 Analysis of drugs in serum (%recovery)
Conc. (μg ml−1)
3.12 6.25 12.5 20 25 30
Cetirizine 100.35 102.66 101.54 96.12 96.12 100.54
Tiaprofenac acid 101.36 100.74 100.77 102.45 92.45 98.72
Diclofenac sodium 100.22 101.99 107.45 102.66 100.29 98.76
Flurbiprofen 103.57 98.65 98.64 103.77 107.45 94.45
Ibuprofen 107.45 97.45 99.12 101.44 101 97.11
Mefenamic acid 105.21 96.21 96.11 108 100.12 99.87
Meloxicam 107.28 100.38 99.21 97.65 96.14 95.46In vitro interaction studies
The application of the method involved the determin-
ation of cetirizine in the presence of NSAIDs at different
pH levels. The results showed the increase and decrease
in peak area values of NSAIDs when compared with
those of alone standards at the same pH levels. The re-
sults clearly indicated the changes in availability values
of cetirizine and NSAIDs in the presence of each other.
From these, it could be stated that %availabilities of
NSAIDs were affected in presence cetirizine and vice
versa. For further verification of the results, complexes
of cetirizine were synthesized with NSAIDs and charac-
terized (Table 6).Characterization of complexes
Infrared studies The assignments of IR bands were
made by comparing the spectra of the pure drugs and
interacting species with the complexes. The major ab-
sorption bands for the infrared frequencies and the cor-
responding assignments are discussed.
In comparison with the reported spectra of cetirizine
and diclofenac sodium (Ihsan et al. 2005; Moffat (2004);
Sultana et al. 2011; Fini et al. 2001), the infrared spec-
trum of the complex showed that NH dimer from 2,700
to 2,400 cm−1 disappeared and the quaternary nitrogen
atom stretching shifted from 3,070 to 3,040 cm−1. Simi-
larly, the aromatic CH and aliphatic CH2 absorption
band ranges shifted from 3,110 to 3,000 and 2,985.6 to
2,914.2 to 3,165 to 3,024 and 2,925.31 to 2,847.61 cm−1,
respectively. A modified band appeared at 1,638.14 cm−1
which indicated neutralization of the carboxylic group
into a carbonyl group. The δ-bending carbonyl mode
shifted from 1,421.57 to 1,200.91 cm−1 to 1,409.31 to
1,237.68 cm−1. From the above results, it has been con-
cluded that, weak charge transfer interaction exists be-
tween the doubly charged piperazine moiety in cetirizine
and diclofenac.
By comparing the cetirizine-flurbiprofen complex from
standard (Ihsan et al. 2005; Moffat 2004; Sultana et al.
2011; Paradkar et al. 2003), the quaternary nitrogen
atom stretching shifted from 3,070 to 3,043 cm−1. The
Table 6 Possible structures and characterizations of complexes
Complex Chemical structure Appearance Solubility Melting point (°C)
Dic-cet White crystalline Soluble in methanol, chloroform, and acetonitrile 108
Mef-cet Off-white amorphous Soluble in methanol, chloroform, and acetonitrile Decompose at 210
Mel-Cet Off-white amorphous Soluble in methanol, chloroform, and acetonitrile 230
Ibu-cet Off-white amorphous Soluble in methanol, chloroform, and acetonitrile 225
Flu-cet White amorphous Soluble in methanol, chloroform, and acetonitrile 110
Dic-cet, diclofenac and cetirizine complex; Mef-cet, mefenamic acid and cetirizine complex; Mel-Cet, meloxicam and cetirizine complex; Ibu-cet, ibuprofen and
cetirizine complex; Flu-cet, flurbiprofen and cetirizine complex.
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appeared as a weak signal with respect to cetirizine.
Characteristic broad peaks in the range of 2,500 to 3,500
and 2,920 cm−1 due to hydrogen bonding and hydroxyl
stretching disappeared whereas carbonyl peak shifted
from 1,698 to 1,654 cm−1 with diminished intensity.
The complex formed between cetirizine and melo-
xicam showed quaternary nitrogen atom stretching at
3,070 cm−1 and NH dimer of amino acid in the region
of 2,700 to 2,400 cm−1 completely disappeared with re-
spect to cetirizine. Characteristic peaks of meloxicam at
1,620 and 3,292 cm−1 for C=O and secondary –NH or –
OH stretching disappeared (Sharma et. al. 2005) while
other sets of signals were the same.
In the complex of mefenamic acid, NH dimer of ami-
no acid and the quaternary nitrogen atom stretching
from 2,700 to 2,400 cm−1 and 3,070 to 3,040 cm−1 disap-
peared. Shifting of some measured peaks was observed
with respect to mefenamic acid (Derle et al. 2008); peaks
of neutralized entity of the carboxylic acid shifted from
1,610 to 1,554.5 and 1,409.9 to 1,292.2 to 1,654 to 1,587
and 1,442 to 1,270 cm−1.
In comparison with IR spectrum of cetirizine (Moffat
2004; Sultana et al. 2011), ibuprofen (Gavrilin and
Pogrebnyak 2001) proved that the quaternary nitrogen
atom stretching and NH dimer of amino acid from 2,700
to 2,400 and 3,070 to 3,040 cm−1 completely disappeared.
Strong absorption bands due to the carboxyl group shifted
from 1,708 to 1,768.90 cm−1.
1H NMR studies The 1H NMR spectra of cetirizine con-
firmed the above results. The de-shielding effect was evi-
dent in complexes on the aromatic NH proton as the
resonance downfield shifted to δ 7.6 ppm. Thus, this pro-
ton appeared in the broad multiplet between δ 6.27 and
7.56 ppm showing 16 aromatic CH protons and the 2 NH+
protons. A singlet was observed at δ 3.3 ppm for methyl
diphenyl CH proton. Triplet at δ 3.71 ppm was obvious
due to four protons on the acyclic CH2 groups adjacent to
NH+ in the piperazine ring and at δ 3.36 ppm was ob-
served for the groups adjacent to the nitrogen hydrochlor-
ide entity. Another singlet at δ 3.61 ppm with two protons
was shown for the CH2 in CH2CH2O entity. The CH2 in
the CH2COOH group appeared as a singlet δ 3.71 ppm. A
very weak singlet was present at δ 10.8 ppm for the one
proton of the carboxylic acid group. In spectra of the
mefenamic acid complex, downfield shift was observed for
aromatic protons. Triplets at δ 3.16 and 3.51 ppm ob-
served for protons on the acyclic CH2 groups adjacent to
NH+ in the piperazine ring. Singlet at δ 10.8 ppm was
present for one proton of the carboxylic acid group. Si-
milar result was observed for cetirizine-flurbiprofen com-
plex, i.e., singlet of carboxylic group proton remained at δ
10.8 ppm and downfield shift observed for aromaticprotons. The protons of piperazine were observed at δ
3.31 to 3.50 ppm. The other properties are shown in
Table 6.Conclusion
The present work described the applicability of simul-
taneous and validated method for the determination and
in vitro interactions of cetirizine in the presence of
NSAIDs as diclofenac sodium, flurbiprofen, ibuprofen,
meloxicam, mefenamic acid, and tirprofenac acid. Further-
more, the method was also found to be applicable in se-
rum and was found useful for therapeutic purposes. The
differences in availabilities of cetirizine with NSAIDs at
three pH levels clearly indicated the interactions of afore-
mentioned drugs. It was further supported by synthesis of
complexes and their characterization. The findings sug-
gested further studies on the co-administration of these
two drugs simultaneously in order to know the pharmaco-
kinetic and pharmacodynamic profiles of the drugs whe-
ther they create synergistic or negative interactions. Till
further research is pursued in this direction, it is highly
recommended to have a suitable time lapse between the
oral uses of these drugs.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HS designed, coordinated, and carried out experiments in the study. HS and
NS drafted the manuscript. MSA supervised the project. All authors read and
approved the final manuscript.
Acknowledgement
The authors are thankful to Dr. Agha Zeeshan Mirza of the Department of
Chemistry, University of Karachi for his help with the manuscript.
Author details
1Research Institute of Pharmaceutical Sciences, Department of
Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi, Karachi
75270, Pakistan. 2Department of Chemistry, University of Karachi, Karachi
75270, Pakistan.
Received: 27 September 2013 Accepted: 5 February 2014
References
Arayne MS, Sultana N, Mirza AZ, Siddiqui FA (2010a) Simultaneous determination of
gliquidone, fexofenadine, buclizine and levocetirizine in dosage formulation
and human serum by RP-HPLC. J Chromatographic Sci 48:382–385
Arayne MS, Sultana N, Shamshad H, Mirza AZ (2010b) Drug interaction studies of
gliquidone with fexofenadine, cetirizine and levocetirizine. Med Chem Res
19:1064–1073
Moffat AC (2004) Clark’s isolation and identification of drugs in pharmaceuticals,
body fluids, and post-mortem material, 3rd edition. The Pharmaceutical Press,
London
Cosmes I, Rodriguez EB (2012) Simultaneous assay and identification of
ibuprofen, phenylephrine HCl and cetirizine HCl in Softgels® by liquid
chromatography. Research & Development, Banner Pharmacaps, High Point,
NC. AAPS 2012-08 02511
Derle DV, Bele M, Kasliwal N (2008) In vitro and in vivo evaluation of mefenamic
acid and its complexes with β-cyclodexin and HP- β-cyclodexin. Asian J
Pharm 2:30–35
Shamshad et al. Journal of Analytical Science and Technology 2014, 5:22 Page 8 of 8
http://www.jast-journal.com/content/5/1/22Fini A, Garuti M, Fazio G, Alvarez FJ, Holgado MA (2001) Diclofenac salts. I. fractal
and thermal analysis of sodium and potassium diclofenac salts. J Pharm Sci
90:2049–2057
Freddy HH, Dharmendra LV (2010) Simultaneous determination of paracetamol,
acetyl salicylic acid, mefenamic acid and cetirizine dihydrochloride in the
pharmaceutical dosage form. E-J Chem 7:S495–S503
Gavrilin MV, Pogrebnyak AV (2001) Synthesis, characterization, and evaluation of
the local irritant action of an ibuprofen- β-cyclodextrin inclusion complex.
Pharm Chem J 35:395–396
Ihsan MK, Barsoum NB, Maha AY (2005) Drug-drug interaction between diclofenac,
cetirizine and ranitidine. J Pharm Biomed Anal 37:655–661
Jain DK, Dubey N, Malav P (2012) Simultaneous estimation of nimesulide,
cetirizine hydrochloride and pseudoephedrine hydrochloride. Asian J Chem
24:4641–4643
Jarkko R, Joan EH, Lindsey OW, Anand B, John PK, Jeevan RK, Cosette JSS, Joseph
WP (2006) In vitro P-glycoprotein inhibition assays for assessment of clinical
drug interaction potential of new drug candidates: a recommendation for
probe substrates. Drug Metab Dispos 34:786–792
Lee JY, Tanabe S, Shimohira H, Kobayashi Y, Oomachi T, Azuma S, Ogihara K,
Inokuma H (2007) Expression of cyclooxygenase-2, P-glycoprotein and
multi-drug resistance-associated protein in canine transitional cell carcinoma.
Res Vet Sci 83:210–216
Padmavathi N, Niranjan MS (2011) Development and validation of HPLC method
for simultaneous estimation of cetirizine dihydrochloride with aceclofenac.
IJPRD 4:268–273
Paradkar A, Maheshwari M, Tyagi A, Chauhan B, Kadam SS (2003) Preparation and
characterization of flurbiprofen beads by melt solidification technique. AAPS
Pharm Sci Tech 4:514–522
Philip YM, Philip M (2010) Combination of cetirizine and mefenamic acid for the
treatment of exacerbations of asthma, WO/2010/116127.
Priya M, Sathya NV, Satyajit M, Jamuna RR (2013) Screening of cetirizine for
analgesic activity in mice. Int J Basic Clin Pharmacol 2:187–192
Renwick AG (1999) The metabolism of antihistamines and drug interactions: the
role of cytochrome P450 enzymes. Clin Exp Allergy 3:116–124
Rewari S, Gupta U (1999) Modification of antihistamine activity of cetirizine by
nimesulide. JAPI 47:389–392
Scott CA, Kelly LC (2003) Antihistamines. Med-Psych Drug-Drug Interactions
44:430–434
Sharma S, Sher P, Badve S, Pawar AP (2005) Adsorption of meloxicam on porous
calcium silicate: characterization and tablet formulation. AAPS PharmSciTech
6:E618–E625
Singh A, Jain R (2003) European patent specification. EP 1005 865 B1.
Sultana N, Arayne MS, Shamshad H, Mirza AZ, Naz MA, Fatima B, Asif M, Mesaik
MA (2011) Synthesis, characterization and biological activities of cetirizine
analogues. Spect-Biomed Appl 26:317–328
Sultana N, Arayne MS, Shamshad H (2010) In vitro studies of the interaction
between cetirizine and H2 receptor antagonists using spectrophotometry
and reversed-phase high-performance liquid chromatography. Med Chem
Res 19:462–474
Suryan AL, Bhusari VK, Rasal KS, Dhaneshwar SR (2011) Simultaneous quantitation
and validation of paracetamol, phenylpropanolamine hydrochloride and
cetirizine hydrochloride by RP-HPLC in bulk drug and formulation.
Int J Pharm Sci Drug Res 3:303–308
Wageh MA, El-S A, El-S M, Ahmed EG (2004) The potential role of
cyclooxygenase-2 inhibitors in the treatment of experimentally-induced
mammary tumour: does celecoxib enhance the anti-tumour activity of
doxorubicin? Pharmacol Res 50:487–498
doi:10.1186/s40543-014-0022-5
Cite this article as: Shamshad et al.: Spectroscopic characterization of
in vitro interactions of cetirizine and NSAIDS. Journal of Analytical Science
and Technology 2014 5:22.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
